Generate a tailored SOP for Dr. Laura Alonso Herranz. Improve your application with a focused, well-structured draft.
Laura Alonso Herranz investigates the underlying mechanisms of atherosclerosis-related vascular diseases using in vitro cellular assays and mouse models of vascular disease, complemented by functional genomics approaches. She is involved in collaborations with prominent entities including Novo Nordisk and AstraZeneca, focusing on cardiovascular and renal disease therapy. In her academic role, Laura contributes to the Bachelor's program in Molecular Medicine, teaching courses that cover topics related to the pathophysiology of cardiovascular conditions, including atherosclerosis and myocardial infarction. She holds a PhD in Molecular Bioscience, where her research focused on the novel mechanisms underlying macrophage contributions to cardiac injury during myocardial infarction. Laura has participated in various conferences and workshops related to her field, actively contributing to the dissemination of research findings.
Department of Computer Science offers tracks in Software Efficiency, Cryptography, and Data Science.